Dr. Eugene Lipov: The Science Behind Stellate Ganglion Block for PTSI
How Stellate Ganglion Block and the DSR protocol are changing the future of PTSI care
In this powerful episode of The MisFitNation, host Rich LaMonica welcomes Dr. Eugene Lipov — physician, researcher, and the world’s leading expert on using Stellate Ganglion Block (SGB) to treat post-traumatic stress.
Dr. Lipov pioneered the use of SGB for trauma recovery in 2006, adapting a decades-old FDA-approved procedure into a breakthrough therapy for PTSD. He later developed the Dual Sympathetic Reset (DSR) protocol, which has helped thousands experience rapid and life-changing relief.
Motivated by his own family’s experience with trauma, Dr. Lipov is also a global advocate for redefining PTSD as Post-Traumatic Stress Injury (PTSI) — a term that removes stigma and reflects the biological nature of the condition.
His work has been featured in The Wall Street Journal, USA Today, Fox National News, NBC, and numerous medical journals. He has testified before Congress, worked with military organizations worldwide, and continues to push trauma treatment into a new era of science-backed innovation.
Learn more at DrEugeneLipov.com
http://thegodshotbook.com
🔥 Like • Comment • Subscribe to support veteran voices and trauma-healing education.
🎙️ More episodes at TheMisFitNation.com
Learn more about your ad choices. Visit megaphone.fm/adchoices
Doctor / Author
Dr. Eugene Lipov is a leading expert in treating post-traumatic stress and the pioneer of using Stellate Ganglion Block (SGB) to alleviate PTSD symptoms. Inspired by his own family’s struggles with trauma, he has dedicated his career to restoring hope for those affected. In 2006, he adapted SGB—an FDA-approved procedure since the 1970's for pain and circulation disorders—as a breakthrough PTSD treatment, later developing the Dual Sympathetic Reset (DSR) protocol for even greater relief.
Beyond his clinical innovations, Dr. Lipov is a relentless advocate for redefining PTSD as post-traumatic stress injury (PTSI) to reduce stigma and shift public understanding. He has testified in 2010 before the U.S. House Committee on Veterans’ Affairs, collaborated with global military and medical communities, and published extensively in leading medical journals. His work has been featured in The Wall Street Journal, USA Today, Fox National News and NBC, underscoring his mission to make effective, science-backed trauma treatments accessible worldwide.
